|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.97 EUR | -1.98% |
|
-1.00% | -20.59% |
| Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
| Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
Heidelberg Pharma AG reported earnings results for the nine months ended August 31, 2023. For the nine months, the company reported sales was EUR 6.63 million compared to EUR 15.69 million a year ago. Revenue was EUR 13.89 million compared to EUR 16.84 million a year ago.
Net loss was EUR 15.84 million compared to EUR 13.22 million a year ago. Basic loss per share from continuing operations was EUR 0.34 compared to EUR 0.39 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.59% | 148M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
HEIDELBERG PHARMA AG 
